Journal of Translational Internal Medicine

Name

Journal of Translational Internal Medicine

Legal name

Journal of Translational Internal Medicine

Website

https://intern-med.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Open access peer-reviewed academic journal published by De Gruyter Brill, covering translational and internal medicine research globally; serves academic and clinical researchers through a cycling model bridging basic science and clinical practice, funded by author-paid APCs.

Ownership category

akta.pro rank

Product category

Academic Journal Publishing

SIC

Miscellaneous Publishing (2741)

akta.pro industry

PRIMARYHLAGALAG

Medical Writing & Publications (Clinical/Safety/HEOR)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Pharmacovigilance & Medical Affairs Services

SECONDARYEDAGAGAA

Medical & Clinical Reference (Physicians, Nursing, Allied Health)

Education/Educational Publishing & Learning Content/Professional & Technical Reference Publishing

SECONDARYHLAIALAF

Translational Medicine & Biomarkers

Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development

Keywords

• Academic journal publishing
• Open access publishing
• Translational medicine
• Peer review services
• Medical journal publishing

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Article Processing Charges (APC): The journal generates revenue through author-paid article processing charges. Original Articles, Reviews, Guideline Interpretation, and Guideline and Consensus articles are charged €2,500 per submission. Shorter formats including Letters, Editorials, Commentaries, Perspectives, and Highlights are charged €800 per submission.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Journal of Translational Internal Medicine (JTIM) is an open access peer-reviewed academic journal that publishes original research articles, reviews, editorials, commentaries, perspectives, highlights, and rapid communications in translational and internal medicine. The journal charges Article Processing Charges (APCs) of €2,500 for original articles/reviews/guideline articles and €800 for shorter formats (letters, editorials, commentaries, perspectives, highlights). Published articles are released under CC-BY-4.0 license and indexed in over 40 academic databases including PubMed, Scopus, and Web of Science.

Differentiator

Problem solved

Functional benefit

Products and services

• Journal of Translational Internal Medicine (JTIM) An open access peer-reviewed academic journal publishing original articles, rapid communications, editorials, reviews, highlights, perspectives, and other content in translational and internal medicine. The journal bridges basic scientific research and clinical science, targeting global academic researchers, clinical practitioners, and medical institutions. Articles are published under CC-BY-4.0 license and indexed in 40+ major academic databases.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Nine partnerships are on record, tiered core and major.

• Scholar Media PublishingcoreOEM/ Whitelabel/ Licensing Partner · 31 December 2013Scholar Media Publishing (hksmp.com) is the owning publisher of the Journal of Translational Internal Medicine. The journal was launched by Scholar Media Publishing in December 2013 and is the primary publication under this imprint.
• De Gruyter BrillcoreChannel Partner/ Reseller/ Distributor · 31 December 2013De Gruyter Brill serves as the global publisher and distributor of the journal. The journal operates on De Gruyter's platform at degruyterbrill.com, utilizing their publishing infrastructure, distribution network, and secure archiving services (Portico).
• Shenyang Medical CollegemajorStrategic or Co-development Partner · 31 December 2013Shenyang Medical College provides institutional support to the Journal of Translational Internal Medicine. The college is located in Shenyang, China.
• International Society of Translational SciencesmajorStrategic or Co-development PartnerInternational Society of Translational Sciences provides academic support to the journal, lending scientific credibility and international perspective to the publication.
• Infectious Diseases Society of ChinamajorStrategic or Co-development PartnerInfectious Diseases Society of China provides academic support to the journal, contributing expertise in infectious diseases research relevant to translational medicine.
• Chinese Hypertension Committee of Chinese Medical Doctors AssociationmajorStrategic or Co-development PartnerChinese Hypertension Committee provides academic support, contributing cardiovascular and hypertension expertise to the journal's translational medicine focus.
• China Alliance of COPDmajorStrategic or Co-development PartnerChina Alliance of COPD provides academic support, contributing respiratory disease expertise to the journal's coverage areas.
• China RTI Optimal Treatment CommitteemajorStrategic or Co-development PartnerChina RTI Optimal Treatment Committee provides academic support, contributing respiratory tract infection treatment expertise to the journal.
• Drug Clinical Assessment Committee of Chinese Pharmaceutical AssociationmajorStrategic or Co-development PartnerDrug Clinical Assessment Committee provides academic support, contributing pharmaceutical and clinical assessment expertise relevant to drug discovery and clinical research.

Scale indicators6 records

Broad incumbents

• PLOS Medicine: PLOS's flagship open-access medical journal covering translational and clinical research. Comparable OA/APC model with a much larger brand and higher Impact Factor, setting an industry benchmark JTIM competes against for top authors.
• Nature Medicine: One of the highest-impact general medical journals covering translational and internal medicine topics. Represents the upper bound of prestige competition for top-tier submissions in JTIM's subject area.
• Science Translational Medicine: AAAS's flagship translational medicine journal. It operates in the same field but with substantially higher prestige, broader author pool, and a hybrid OA model, representing JTIM's aspirational ceiling.

Regional players

• MedComm: A Wiley-published, China-rooted open-access biomedical journal. Strongly comparable in geographic/institutional origin and OA APC-based economics, with overlap in target author demographics.

Emerging players

• eLife: A nonprofit open-access journal publishing across life sciences and medicine. While broader in scope, it competes for the same OA-author pool and represents a model JTIM's open-access positioning aligns with.
• Translational Medicine Communications: A newer BMC open-access journal focused on translational medicine. Overlaps with JTIM's mission and OA model but with a smaller, less established brand.

Direct peers

• Journal of Translational Medicine: A Springer Nature/BMC open-access journal dedicated to translational medicine research. It is the most direct competitor to JTIM in terms of scope, audience, and OA business model.
• Annals of Translational Medicine: An open-access translational medicine journal with a similarly broad scope and author base, including significant China-based editorial contribution. Direct overlap with JTIM in audience and article categories.
• Chinese Medical Journal: A long-established, English-language medical journal from the Chinese Medical Association. Shares the Chinese institutional publishing context and serves a partially overlapping author and reader base.
• Frontiers in Medicine: A large open-access medical journal publishing across internal medicine and translational research. Comparable OA APC-based model and similar multidisciplinary reach.

Market position

Customer concentration

• LinkedInlinkedin.com/company/journal-of-translational-internal-medicine

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Journal of Translational Internal Medicine